Our old friends at Aquis-listed TruSpine (TSP) have been at it again, releasing interims results to September and announcing yet more delays for its Cervi-LOK product during no-one-is-watching week. Oh, and the cash is running out yet again. What’s not to like?

AIM-listed Haydale Graphene (HAYD) has offered up its interims to December 2020 today and whilst the company flags increased sales of functionalised inks graphene and points to falling admin costs and operating losses, these are on an adjusted basis. The unadjusted truth is that sales of £1.277 million were down from £1.347 million the previous year and the company lost £2 million in total comprehensive loss (although this is marked as being for the year – not that there was an cut’n’paste laziness!)

When I last wrote about AIM-listed Advanced Oncotherapy, at the end of October last year, it had just announced a placing at 30p per share to raise £7.7 million and my back-of-a-fag-packet suggested that despite the new money, it was placing ahoy. Well, yesterday that placing duly arrived with £6 million raised at a rather more impressive 40p. So will this be the last time the company passes round the hat? 

AIM-listed Yu Group (YU.) announced its Interims to June this morning – deadline day, never a good sign – and the balance sheet shows it is in a mess.

AIM-listed jam-tomorrow investor in cash-guzzling unlisted dogs Tern plc (TERN) raised an impressive £1.5 million recently, and claimed it had £0.8 million of cash on the books as at the end of June. Sounds impressive, but I fear that the cash may not last long…

Having made a total shambles of its half-year trading statement to the end of December, contradicting itself the very next day, AIM-listed Haydale (HAYD) has offered up dire interim results. The company will need more cash – and given the fiasco last time, that spells bad news for shareholders.

I suspect that ShareProphets readers already know the answer: that the news is really not all that great and thus it looks like a ramparoonie of the first order! Surely it could not be placing ahoy, could it?

AIM-listed energy supplier with recent accounting issues Yu Group (YU.) has released a full year trading statement. Like its half year trading statement last year, it is again full of holes: it tells us about the cash, but what about payables? And whilst losses appear to have been reduced, references to adjusted EBITDA don’t fool me: the company is still leaking cash.

You can’t say you were not warned on this website, but the old adage that when a bad company meets (perhaps, or perhaps not) good management it is the reputation of the former which prevails has once again proved true for AIM-listed St James House (SJH), formerly Boxhill (BOX), the past home of Lord Razzall. This afternoon we were treated to a 1pm Trading update: Friday lunchtime – definitely no-one-is-watching o’clock! Uh-oh…………

AIM-listed utilities provider Yu Group (YU.) has offered up a trading statement for the first six months of the year. The numbers offered are full of holes, leaving more questions unanswered and we are told there will be an adjusted (ie bullshit) EBITDA (double bullshit) earnings loss of between £2.5-£3 million. Goodness knows what the actual bottom-line loss will be then. And as for the cash figures offered...

AIM-listed, Houston headquartered, Cayman Islands registered oil/gas play Frontera (FRR), whose operations are in Georgia (and if that’s not a Red Flag….) has confirmed gas flow rates from its Dino-2 well in the Taribani complex. It flowed at 315 bbls per day – well, at least part of one day. Apparently that’s commercial, but I doubt shareholders can count their winnings just yet.

So after my piece HERE wondering why AIM-listed Advanced Oncotherapy (AVO) was up 20-odd per cent it turns out that a research note was put out on the RNS system. The research note was from an outfit called Goetzpartners Securities Limited, which claims to be a leading pan-European investment bank and research firm. Right…. So who paid for this research, and is it worth the paper it is written on?

AIM-listed Karelian Diamonds (KDR) rather bucked the trend yesterday when it put on 10.6% on a day the markets were again sinking. We all know Karelian needs a placing urgently, to keep the lights on. So what caused the rise? Oh, hang on, there are three RNSs which were released just after 3.40pm – and they are all good 'news', except for one small detail…

Prof. Richard Conroy's AIM-listed Karelian Diamond Resources (KDR) is apparently making house broker Beaufort Securities “very excited”. Obviously that is entirely because of the company’s ramptastic RNS (which saw the shares fall - why might that be?), and nothing to do with its train-wreck of a balance sheet and the bail-out refinancing it needs. No, it is not because Beaufort can see a nice commission cheque on the way.

UK Oil & Gas (UKOG) nutter Michael Boyle wants to trap me and report me to the FCA. What a prize poltroon. Andrew Bell has been selling lots of UK Oil & Gas shares but - with millions still on the book - tries to argue that they are cheap. Hmmm. I have a second  maths lesson for my friend Mr Bell following on from this one yesterday. Then it is onto my old friend the offshore based asset stripper Jim Mellon and one of the many dogs in his stable, the related party snakefest that is FastForward (FFWD). Clearly it is placing ahoy as the company has zero cash and grotesque PLC costs but I explain why the shares, at 9.5p, are monstrously overvalued - fair value is sub 5p. Sorry Jim.

21st Century Technology (C21) “is pleased to announce that it has been selected by OFJ Connections Gatwick Airport to provide integrated real-time passenger information and connected bus systems”. The shares have currently responded more than 14% higher to 3p – though this comparing to 5p early this year…

“MediaZest (MDZ), the creative audio-visual company, is pleased to provide shareholders with final results for the year ended 31 March 2016… Best ever financial results with turnover of £3,144,000 and EBITDA profit of £58,000”. Hmmm, let’s take a closer look…

Commenting on today-announced results for the company’s year ended 30th April 2016, Ilika (IKA) Chairman, Mike Inglis, notes “since my appointment as Non-Executive Chairman at the AGM last September, I have been very encouraged to see the technical progress and increased commercial focus at Ilika. The definition of a clear solid state battery roadmap and the launch of the Stereax M250 have been important milestones on the road to commercial success”. The following reviews with the shares currently more than 14% lower, at 45p…

Shares in Advanced Oncotherapy (AVO) are ahead smartly currently on the back of an announcement headlined “£24m financing secured for the provision of vendor financing by AVO for the Harley Street project”. Hmmm, let’s take a look…

Having spotted the appointment of another joint Broker to AIM-listed Bushveld Minerals (BMN) on 8 April – see HERE – I had wondered if it was placing ahoy. Last Thursday saw the suspension of the shares announced by AIM at lunch-time, pending an announcement, although it took until after-hours on Friday for the company to bother to comment.

Conroy Gold (CGNR) has today put out a laughable release claiming that it is "targetting" 5 million ounces of gold at its deposits on the Irish/Ulster border. I, as you know, am still targeting getting up close and personal with Britain's most talented chanteuse but I've been on my quest a lot less long than Conroy has been, unlike the AIM tiddler I'm pursuing my quest with my own money and there is almost as much evidence to support my dreams as that of the AIM listed money cruncher. That is to say sweet FA.

Following a trading warning that saw shares in Rex Bionics (RXB) fall to around 70p in late 2014, I concluded that this is a type of company you want to succeed but, with it looking to be some way from being able to prove its commerciality and cashburn concerns until it gets there, the shares didn’t look to appeal as an investment – see HERE. With the shares now at 43.5p, the following updates post a trading statement today that the company “is pleased to provide”…

Solo Oil (SOLO) the David Lenigas created POS cannot stop telling us more ramptastic news from Horse Hill yet its shares are sliding again today. Why? Well there is a missing RNS on its acqusition out in Bongo Bongo land and the small matter of the placing it needs to do ASAP to pay for that deal and to stop the company going bust.

I commented on shares in remote tracking and monitoring company Starcom (STAR) on the back of an April 2015 profit warning which saw them then trade approaching 15% lower at 7.125p. My caution of then has proved justified as I now update with the shares further lower, at just 1.5p, on the back of the company’s announcement of results for the 2015 calendar year…

Shares in e-procurement software provider, EU Supply (EUSP) currently trade approaching 30% lower today, at 4.5p, on the back of a “trading update”. Hmmm, I wonder what that has in store? 

Yes I have indeed done just that, or I think I have. The olive harvest saga continues and the snow has started on the mountains above the Greek Hovel, pictures later. In this podcast I look at Jabba The Hutt ramping Afriag (AFRI) and warn you what will happen next. Then a comment on LGO Energy (LGO) before heading onto PeerTV (PTV) and - in an unusual manner - I cover ValiRx (VAL). You see Satu I am a man of my word, Halosource (HALO) gets "the treatment" as does Gary Newman for buying into corporate bullshit speak. Then it is onto Photosntar Led (PSL), Fitbug (FITB) and finally InternetQ (INTQ).

Another set of numbers from the 14 ShareProphets AIM-China Filthy Forty which were due to report by Wednesday of this week has been chalked up. MoneySwap plc (SWAP) reports a full year (to end Mar 2015) loss of $3.2 million. Against a market capitalisation of £11.1 million (source: ADVFN) that doesn’t look too clever. But it gets worse, because there is an audit Emphasis of matter with regard to sign-off of the company as a going concern: the company will be required to raise funds. Neon signs: placing ahoy!

Shares in Image Scan Holdings (IGE) currently trade more than 20% lower today, at 1.875p, on the back of an announcement which includes that for the six months ended 31st March “a pre-tax trading loss of around £380k is expected” and that “order intake so far this year has been slow”. Having previously warned HERE and HERE, the following updates…